BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31323733)

  • 1. Peptidoglycan O-Acetylation as a Virulence Factor: Its Effect on Lysozyme in the Innate Immune System.
    Brott AS; Clarke AJ
    Antibiotics (Basel); 2019 Jul; 8(3):. PubMed ID: 31323733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the Structure-Function Relationship of Lysozyme Resistance in Staphylococcus aureus by Peptidoglycan O-Acetylation Using Molecular Docking, Dynamics, and Lysis Assay.
    Pushkaran AC; Nataraj N; Nair N; Götz F; Biswas R; Mohan CG
    J Chem Inf Model; 2015 Apr; 55(4):760-70. PubMed ID: 25774564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori peptidoglycan modifications confer lysozyme resistance and contribute to survival in the host.
    Wang G; Lo LF; Forsberg LS; Maier RJ
    mBio; 2012 Dec; 3(6):e00409-12. PubMed ID: 23221800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cell wall peptidoglycan O-acetylation on the pathogenesis of Staphylococcus aureus in septic arthritis.
    Baranwal G; Mohammad M; Jarneborn A; Reddy BR; Golla A; Chakravarty S; Biswas L; Götz F; Shankarappa S; Jin T; Biswas R
    Int J Med Microbiol; 2017 Oct; 307(7):388-397. PubMed ID: 28802679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De-O-acetylation of peptidoglycan regulates glycan chain extension and affects in vivo survival of Neisseria meningitidis.
    Veyrier FJ; Williams AH; Mesnage S; Schmitt C; Taha MK; Boneca IG
    Mol Microbiol; 2013 Mar; 87(5):1100-12. PubMed ID: 23373517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidoglycan O-acetylation is functionally related to cell wall biosynthesis and cell division in Streptococcus pneumoniae.
    Bonnet J; Durmort C; Jacq M; Mortier-Barrière I; Campo N; VanNieuwenhze MS; Brun YV; Arthaud C; Gallet B; Moriscot C; Morlot C; Vernet T; Di Guilmi AM
    Mol Microbiol; 2017 Dec; 106(5):832-846. PubMed ID: 28960579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity.
    Bera A; Biswas R; Herbert S; Götz F
    Infect Immun; 2006 Aug; 74(8):4598-604. PubMed ID: 16861647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SliC is a surface-displayed lipoprotein that is required for the anti-lysozyme strategy during Neisseria gonorrhoeae infection.
    Zielke RA; Le Van A; Baarda BI; Herrera MF; Acosta CJ; Jerse AE; Sikora AE
    PLoS Pathog; 2018 Jul; 14(7):e1007081. PubMed ID: 29975784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lysozyme-induced peptidoglycan N-acetylglucosamine deacetylase PgdA (EF1843) is required for Enterococcus faecalis virulence.
    Benachour A; Ladjouzi R; Le Jeune A; Hébert L; Thorpe S; Courtin P; Chapot-Chartier MP; Prajsnar TK; Foster SJ; Mesnage S
    J Bacteriol; 2012 Nov; 194(22):6066-73. PubMed ID: 22961856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SpxB regulates O-acetylation-dependent resistance of Lactococcus lactis peptidoglycan to hydrolysis.
    Veiga P; Bulbarela-Sampieri C; Furlan S; Maisons A; Chapot-Chartier MP; Erkelenz M; Mervelet P; Noirot P; Frees D; Kuipers OP; Kok J; Gruss A; Buist G; Kulakauskas S
    J Biol Chem; 2007 Jul; 282(27):19342-54. PubMed ID: 17485463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a new family of enzymes with potential O-acetylpeptidoglycan esterase activity in both Gram-positive and Gram-negative bacteria.
    Weadge JT; Pfeffer JM; Clarke AJ
    BMC Microbiol; 2005 Aug; 5():49. PubMed ID: 16111493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic Pathways for Peptidoglycan O-Acetylation and De-O-Acetylation.
    Sychantha D; Brott AS; Jones CS; Clarke AJ
    Front Microbiol; 2018; 9():2332. PubMed ID: 30327644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate specificity and kinetic characterization of peptidoglycan O-acetyltransferase B from Neisseria gonorrhoeae.
    Moynihan PJ; Clarke AJ
    J Biol Chem; 2014 Jun; 289(24):16748-60. PubMed ID: 24795044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-Acetylated peptidoglycan: controlling the activity of bacterial autolysins and lytic enzymes of innate immune systems.
    Moynihan PJ; Clarke AJ
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1655-9. PubMed ID: 21889603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of O-acetylpeptidoglycan esterase: a novel enzyme discovered in Neisseria gonorrhoeae.
    Weadge JT; Clarke AJ
    Biochemistry; 2006 Jan; 45(3):839-51. PubMed ID: 16411760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterococcus faecalis constitutes an unusual bacterial model in lysozyme resistance.
    Hébert L; Courtin P; Torelli R; Sanguinetti M; Chapot-Chartier MP; Auffray Y; Benachour A
    Infect Immun; 2007 Nov; 75(11):5390-8. PubMed ID: 17785473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus.
    Bera A; Herbert S; Jakob A; Vollmer W; Götz F
    Mol Microbiol; 2005 Feb; 55(3):778-87. PubMed ID: 15661003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro characterization of the antivirulence target of Gram-positive pathogens, peptidoglycan O-acetyltransferase A (OatA).
    Sychantha D; Jones CS; Little DJ; Moynihan PJ; Robinson H; Galley NF; Roper DI; Dowson CG; Howell PL; Clarke AJ
    PLoS Pathog; 2017 Oct; 13(10):e1006667. PubMed ID: 29077761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of beta-lactam antibiotics on peptidoglycan synthesis in growing Neisseria gonorrhoeae, including changes in the degree of O-acetylation.
    Blundell JK; Perkins HR
    J Bacteriol; 1981 Aug; 147(2):633-41. PubMed ID: 6790518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system.
    Boneca IG; Dussurget O; Cabanes D; Nahori MA; Sousa S; Lecuit M; Psylinakis E; Bouriotis V; Hugot JP; Giovannini M; Coyle A; Bertin J; Namane A; Rousselle JC; Cayet N; Prévost MC; Balloy V; Chignard M; Philpott DJ; Cossart P; Girardin SE
    Proc Natl Acad Sci U S A; 2007 Jan; 104(3):997-1002. PubMed ID: 17215377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.